Reply to Kalow et al

Pharmacogenomics Journal

Volumn 1, Issue 4, 2001, Pages 235-236

  Nebert, D W ^a   Menon, A G ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 16544382916     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500062     Document Type: Letter

References (9)

1. Nebert DW, Menon A. The Pharmacogenomics Journal 2001 1: 19–22
2. Kalow W et al. The Pharmacogenomics Journal 2001 1: 234–235
3. Kalow W, Bertilsson L. Advanc Drug Res 1994 23: 1–53
4. Dipple KM, McCabe ERB. Am J Hum Genet 2000 66: 1729–1735
5. Evans DAP et al. Br Med J 1960 2: 485–498
6. Woolhouse NM et al. Clin Pharmacol Ther 1979 26: 584–591
7. Nebert DW. Eur J Pharmacol 2000 410: 107–120
8. Goldstein JA, de Morais SM. Pharmacogenetics 1994 4: 285–299
9. Oscarson M et al. http://www.imm.ki.se/CYPalleles/ 2001